Provided by Tiger Trade Technology Pte. Ltd.

Horizon Kinetics Blockchain Development ETF

33.43
-0.4110-1.21%
Volume:2K
Turnover:83.25K
Market Cap:24.23M
PE:- -
High:33.43
Open:33.30
Low:33.30
Close:33.84
52wk High:36.27
52wk Low:29.01
Shares:725.00K
Float Shares:725.00K
Volume Ratio:2.27
T/O Rate:0.34%
Dividend:0.76
Dividend Rate:2.28%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Philips Prices EUR 650 Million EU Green Bond Offering

Reuters
·
Aug 25

Rocket Doctor AI Grants 24,000 Stock Options at $0.70 Per Share to Consultants

Reuters
·
Aug 25

AutoZone Updates Financial Calendar with Quarterly Earnings Release, Conference Call

Reuters
·
Aug 25

Cboe Global Markets Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 25

WeShop Posts H1 2026 Earnings Release on Investor Relations Website

Reuters
·
Aug 25

Reitir Publishes H1 2026 Financial Results Report

Reuters
·
Aug 25

Orangekloud Signs Definitive Deal to Acquire VeVe Operator Orbis, Plans NASDAQ Ticker Change to VEVE

Reuters
·
Aug 25

OceanLight Acquisition Issues 1.5 Million Additional Units in IPO Over-Allotment Exercise at USD 10 Each

Reuters
·
Aug 25

Weatherford, NCS Multistage Set Aug. 31 Election Deadline Ahead of Anticipated Sept. 1 Merger Close

Reuters
·
Aug 25

FingerMotion Takes 9.9% Stake in Lyken.AI

Reuters
·
Aug 25

Micropolis Robotics Becomes Physical AI Solutions Provider to ADNOC

Reuters
·
Aug 25

Wearable Devices H1 FY26 Net Loss Widens to USD 5.52 Million; Revenue Rises to USD 350,000

Reuters
·
Aug 25

LPL Financial Names Jonathan Lewis Chief Technology and Information Officer

Reuters
·
Aug 25

Xanadu Quantum to Host Investor, Analyst Technology Roadmap Presentation

Reuters
·
Aug 25

Bank of America Tops 10% Stake in Lakefront Biotherapeutics Voting Rights Disclosure

Reuters
·
Aug 25

Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus

Reuters
·
Aug 25

Avalyn Pharma Advances Inhaled Pirfenidone AP01 in Phase 2b MIST Trial for Progressive Pulmonary Fibrosis

Reuters
·
Aug 25

Oruka Therapeutics Names Todd Edwards Chief Commercial Officer

Reuters
·
Aug 25

Belite Bio to Host Virtual Commercial Day on Tinlarebant Opportunity in Stargardt Disease Type 1

Reuters
·
Aug 25

Coda Octopus to Host Fiscal Q3 2026 Earnings Call

Reuters
·
Aug 25